Injective (INJ) is currently priced at $3.80, exhibiting a 24-hour change of 4.08%. The daily trading range has been relatively tight, with a high of $4.08 and a low of $3.63, indicating moderate volatility.

Trading volume stands at approximately 169.9 million, representing a volume-to-market cap ratio of 44.56%, suggesting strong market participation. The hourly moving averages indicate positive momentum, particularly with the 55 SMA at $3.58 showing a significant increase of 6.02%, reinforcing bullish sentiment.

The 1-hour RSI is at 66, nearing overbought territory, while the 7-day RSI at 58 indicates healthy momentum without excessive buying pressure. Over the last week, INJ has appreciated by 16.27%, and over the past 30 days, it has gained nearly 33.69%, reflecting a strong upward trend.

Despite the potential for a pullback due to the elevated 1-hour RSI, the overall trend remains bullish supported by positive price changes over various time frames. The all-time high of $52.62, reached in March 2024, highlights significant upside potential if the current momentum can be sustained.

In conclusion, the technical indicators, including moving averages and RSI levels, support a bullish outlook for Injective (INJ). Therefore, I recommend a Buy rating, as the market shows strong upward momentum and significant growth potential in the near term.